iNtRON Biotechnology Inc (048530) — Financial Flexibility Index

Latest as of September 2025: -0.21x

iNtRON Biotechnology Inc (048530) has a Financial Flexibility Index of -0.21x as of September 2025. Free cash flow of ₩-993.53 Million (operating CF ₩-993.53 Million minus capex ₩0.00) represents 0% of total liabilities (₩4.73 Billion). Also explore iNtRON Biotechnology Inc equity growth rate to track the company's year-over-year net asset growth rate.

Financial Flexibility Index

-0.21x
Free Cash Flow / Total Liabilities

Free Cash Flow

₩-993.53 Million
Operating CF − Capex

Total Liabilities

₩4.73 Billion
KRW

Capital Expenditures

₩0.00
KRW

iNtRON Biotechnology Inc Financial Flexibility Index (2012–2024)

Historical Financial Flexibility Index trend for iNtRON Biotechnology Inc across 11 annual periods. Check iNtRON Biotechnology Inc PP&E and investment ratio to assess the company's strategic physical and investment asset allocation.

Annual Financial Flexibility Index for iNtRON Biotechnology Inc (2012–2024)

Year-by-year free cash flow to debt coverage for iNtRON Biotechnology Inc. For the full company profile including market capitalisation, see iNtRON Biotechnology Inc stock valuation.

Year Flexibility Index Free Cash Flow (KRW) Operating CF Total Liabilities YoY Change
2024 0.40x ₩1.05 Billion ₩-138.47 Million ₩2.60 Billion ▼ -94.0%
2023 6.74x ₩12.67 Billion ₩3.12 Billion ₩1.88 Billion ▲ +2755.7%
2022 0.24x ₩8.21 Billion ₩5.98 Billion ₩34.78 Billion ▼ -37.1%
2021 0.38x ₩19.52 Billion ₩16.47 Billion ₩52.02 Billion ▼ -52.5%
2020 0.79x ₩11.98 Billion ₩7.13 Billion ₩15.16 Billion ▲ +3815.8%
2019 -0.02x ₩-512.11 Million ₩-812.48 Million ₩24.07 Billion ▼ -107.0%
2018 0.30x ₩4.75 Billion ₩4.20 Billion ₩15.70 Billion ▲ +203.6%
2017 -0.29x ₩-4.49 Billion ₩-5.47 Billion ₩15.38 Billion ▼ -3918.3%
2016 0.01x ₩79.99 Million ₩-4.64 Billion ₩10.46 Billion ▼ -99.4%
2015 1.35x ₩8.00 Billion ₩1.70 Billion ₩5.93 Billion ▲ +6382.5%
2012 0.02x ₩160.60 Million ₩-331.01 Million ₩7.72 Billion —
Financial Flexibility Index = (Operating CF − Capex) / Total Liabilities = Free Cash Flow / Total Liabilities